Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

70.23

-1.15 (-1.61%)

At close: May 9, 2025, 4:00 PM

69.00

-1.23 (-1.75%)

After-hours: May 9, 2025, 6:06 PM EDT

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $7.45 billion as of May 9, 2025. Its market cap has increased by 212.80% in one year.

Market Cap

7.45B

Enterprise Value

6.88B

1-Year Change

212.80%

Ranking

#1004

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $7.45B, an increase of 2,531.63%. That is a compound annual growth rate of 16.78%.

Market Cap History

Date	Market Cap	% Change
May 8, 2025	7.57B	43.37%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	674.60B
Johnson & Johnson	374.53B
UnitedHealth Group	349.75B
AbbVie	328.29B
Novo Nordisk	287.72B
Abbott Laboratories	233.14B
Novartis AG	215.89B
AstraZeneca	208.98B

Market Cap Rankings